These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 9448105
1. Influence of albumin on enantioselective local disposition of BOF-4272, a xanthine oxidase inhibitor with chiral sulfoxide, in rat liver. Nishimura M, Yamaoka K, Naito S, Nakagawa T. Biol Pharm Bull; 1997 Dec; 20(12):1285-9. PubMed ID: 9448105 [Abstract] [Full Text] [Related]
2. Effect of temperature in perfusate on local hepatic disposition of BOF-4272, a new xanthine oxidase inhibitor. Nishimura M, Yamaoka K, Yasui H, Naito S, Nakagawa T. Biol Pharm Bull; 1995 Jul; 18(7):980-3. PubMed ID: 7581254 [Abstract] [Full Text] [Related]
3. Hepatic local disposition of a drug with high protein binding and high hepatic clearance using BOF-4272 as a model drug. Nishimura M, Yamaoka K, Naito S, Nakagawa T. Biol Pharm Bull; 1996 Sep; 19(9):1197-202. PubMed ID: 8889040 [Abstract] [Full Text] [Related]
7. Study of the enantioselective binding between BOF-4272 and serum albumins by means of high-performance frontal analysis. Shibukawa A, Kadohara M, He JY, Nishimura M, Naito S, Nakagawa T. J Chromatogr A; 1995 Mar 03; 694(1):81-9. PubMed ID: 7719472 [Abstract] [Full Text] [Related]
8. Biotransformation of the xanthine oxidase inhibitor BOF-4272 and its metabolites in the liver and by the intestinal flora in rat. Naito S, Nishimura M. Xenobiotica; 2000 Jan 03; 30(1):103-9. PubMed ID: 10659955 [Abstract] [Full Text] [Related]
9. In vitro and in vivo studies on the stereoselective pharmacokinetics and biotransformation of an (S)-(-)- and (R)-(+)-pyrazolotriazine sulfoxide in the male rat. Naito S, Nishimura M. Xenobiotica; 2002 Jun 03; 32(6):491-503. PubMed ID: 12160482 [Abstract] [Full Text] [Related]
12. Evaluation of the pharmacological actions and pharmacokinetics of BOF-4272, a xanthine oxidase inhibitor, in mouse liver. Naito S, Nishimura M, Tamao Y. J Pharm Pharmacol; 2000 Feb 03; 52(2):173-9. PubMed ID: 10714947 [Abstract] [Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of a novel xanthine oxidase inhibitor, BOF-4272, in healthy volunteers. Uematsu T, Nakashima M. J Pharmacol Exp Ther; 1994 Aug 03; 270(2):453-9. PubMed ID: 8071837 [Abstract] [Full Text] [Related]
14. Metabolic pathways and pharmacokinetics of BOF-4272, a sulfoxide-containing drug, in the dog: in vivo and in vitro studies. Naito S, Nishimura M, Yoshitsugu H, Nogawa H. Biol Pharm Bull; 1999 Dec 03; 22(12):1391-5. PubMed ID: 10746178 [Abstract] [Full Text] [Related]
15. Xanthine oxidase inhibition attenuates kupffer cell production of neutrophil chemoattractant following ischemia-reperfusion in rat liver. Matsumura F, Yamaguchi Y, Goto M, Ichiguchi O, Akizuki E, Matsuda T, Okabe K, Liang J, Ohshiro H, Iwamoto T, Yamada S, Mori K, Ogawa M. Hepatology; 1998 Dec 03; 28(6):1578-87. PubMed ID: 9828222 [Abstract] [Full Text] [Related]
17. Mechanism of inhibition of xanthine oxidase with a new tight binding inhibitor. Okamoto K, Nishino T. J Biol Chem; 1995 Apr 07; 270(14):7816-21. PubMed ID: 7713871 [Abstract] [Full Text] [Related]
18. Moment analysis of stereoselective biliary excretion and chiral inversion of ketoprofen enantiomers in perfused rat liver. Yasui H, Yamaoka K, Dote N, Nakagawa T. J Pharm Sci; 1995 Nov 07; 84(11):1327-31. PubMed ID: 8587051 [Abstract] [Full Text] [Related]
19. Evaluation of protein binding effect on local disposition of oxacillin in rat liver by a two-compartment dispersion model. Yano Y, Yamaoka K, Minamide T, Nakagawa T, Tanaka H. J Pharm Pharmacol; 1990 Sep 07; 42(9):632-6. PubMed ID: 1981901 [Abstract] [Full Text] [Related]
20. Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. Role of protein binding. Mehvar R, Reynolds J. Drug Metab Dispos; 1996 Oct 07; 24(10):1088-94. PubMed ID: 8894509 [Abstract] [Full Text] [Related] Page: [Next] [New Search]